{{Rsnum
|rsid=953741
|Gene=ZFP2
|Chromosome=5
|position=178902845
|Orientation=plus
|GMAF=0.1777
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ZFP2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 43.4 | 41.6 | 15.0
| HCB | 88.7 | 11.3 | 0.0
| JPT | 96.5 | 3.5 | 0.0
| YRI | 93.2 | 6.1 | 0.7
| ASW | 84.2 | 15.8 | 0.0
| CHB | 88.7 | 11.3 | 0.0
| CHD | 90.8 | 9.2 | 0.0
| GIH | 57.0 | 41.0 | 2.0
| LWK | 92.7 | 7.3 | 0.0
| MEX | 58.6 | 37.9 | 3.4
| MKK | 87.2 | 12.8 | 0.0
| TSI | 54.9 | 39.2 | 5.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=20560679
|Title=Response to Methadone Maintenance Treatment is Associated with the MYOCD and GRM6 Genes
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}